The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Significance and reliability of pathologic marker Ki-67 in patients with neuroendocrine cancers.
Simron Singh
Disclosure not yet available
Yael Feinberg
Disclosure not yet available
Corwyn Rowsell
Disclosure not yet available
Calvin Law
Disclosure not yet available